GOPs face Super Tuesday and an IP lawsuit

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

GOPs face Super Tuesday and an IP lawsuit

As the US Republican presidential candidates await the results of Super Tuesday, they are also being sued in California for patent infringement

Today, 10 US states are holding primary elections or caucuses that will help decide the Republican party nominee for the 2012 US presidential election.

The candidates include Newt Gingrich, Rick Santorum and Mitt Romney, all of whom are also being sued in the US District Court for the Central District of California by an IP lawyer and patent owner.

The complaint alleges infringement of US patent number 7,644,122, which covers a method of online communication with both online and offline recipients. The lawsuit claims that the GOPs’ (and 1,000 others’) business Facebook accounts infringe the ‘122 patent, which is owned by EveryMD.

EveryMD’s website provides home pages for over 300,000 doctors and allows patients to obtain information about and communicate with them.

The business is a partnership of Frank Weyer and Troy Javaher, who both own the ‘122 patent. Weyer is an attorney with Techcoastlaw in California, which describes itself as a “cutting edge internet law” firm.

According to the complaint, EveryMD is suing the GOP candidates and other individuals (who are unidentified in the complaint) because Facebook refused to take a licence or purchase the ‘122 patent.

“Facebook’s failure to purchase the ‘122 patent…leaves holders of Facebook business accounts liable for infringement of the ‘122 patent for unauthorized commercial use of Facebook pages produced by Facebook using the ‘122 patent,” said the complaint.

Business account holders were offered a chance to take a licence for a reduced price of $500 per account in January 2011 to avoid liability, but none of the candidates agreed, according to the complaint.

EveryMD also sued Facebook in 2010 in the same California court, and Facebook subsequently requested reexamination of the ‘122 patent with the USPTO.

Facebook has argued that EveryMD’s invention is an obvious combination of technologies that existed at the time the patent application was filed in 1999.

The patents have so far been found invalid in reexamination. EveryMD has appealed to the Board of Patent Appeals and Interferences and claims that Facebook’s recent IPO prospectus proves the social network relies on the patented technology for its success.

The GOP candidates named in the most recent suit have until April 1 to respond - two days before primaries are scheduled to take place in Washington DC, Maryland and Wisconsin.

more from across site and SHARED ros bottom lb

More from across our site

News of Via Licensing Alliance selling its HEVC/VCC pools and a $1.5 million win for Davis Polk were also among the top talking points
The winner of a high-profile bidding war for Warner Bros Discovery may gain a strategic advantage far greater than mere subscriber growth - IP licensing leverage
A vote to be held in 2026 could create Hogan Lovells Cadwalader, a $3.6bn giant with 3,100 lawyers across the Americas, EMEA and Asia Pacific
Varuni Paranavitane of Finnegan and IP counsel Lisa Ribes compare and contrast two recent AI copyright decisions from Germany and the UK
Exclusive in-house data uncovered by Managing IP reveals French firms underperform on providing value equivalent to billing costs and technology use
The new court has drastically changed the German legal market, and the Munich-based firm, with two recent partner hires, is among those responding
Consultation feedback on mediation and arbitration rules and hires for Marks & Clerk and Heuking were also among the major talking points
Nick Groombridge shares how an accidental turn into patent law informed his approach to building a practice based on flexibility and balancing client and practitioner needs
Clarivate’s Ed White discusses the joy of measuring innovation and why patent attorneys are a special breed
National groups for the UK and the Netherlands have flagged concerns with the choice of venue, following a formal complaint from Australia’s national group
Gift this article